Reckitt Benckiser Group (OTCMKTS:RBGLY) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLYGet Rating) from a sell rating to a hold rating in a report released on Thursday, reports.

According to Zacks, “Reckitt Benckiser Group Plc engages in manufacturing and distributing household, toiletry, pharmaceutical and food products. The company offers antiseptic liquids, depilatory products, medicated sore throat products, condoms, cold/flu products, acne treatment products, analgesics and upper gastro-intestinal products, foot care and comfort footwear products, denture care and dry skin care products, fabric care products, surface care products and polishes/waxes. Reckitt Benckiser Group is based in Slough, the United Kingdom. “

RBGLY has been the topic of several other reports. UBS Group raised their price objective on shares of Reckitt Benckiser Group from GBX 7,700 ($96.89) to GBX 8,000 ($100.67) in a research report on Tuesday, May 3rd. Jefferies Financial Group downgraded shares of Reckitt Benckiser Group from a hold rating to an underperform rating in a report on Wednesday, March 23rd. Societe Generale downgraded shares of Reckitt Benckiser Group from a buy rating to a sell rating in a report on Wednesday, March 16th. Barclays lifted their target price on shares of Reckitt Benckiser Group from GBX 9,100 ($114.51) to GBX 9,300 ($117.03) in a report on Tuesday, May 3rd. Finally, Exane BNP Paribas raised shares of Reckitt Benckiser Group from an underperform rating to a neutral rating in a report on Monday, March 14th. Three investment analysts have rated the stock with a sell rating, two have issued a hold rating and eight have assigned a buy rating to the company’s stock. According to, Reckitt Benckiser Group has an average rating of Hold and a consensus price target of $6,364.00.

Shares of Reckitt Benckiser Group stock opened at $15.65 on Thursday. Reckitt Benckiser Group has a 1 year low of $14.40 and a 1 year high of $19.17. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.62 and a quick ratio of 0.44. The company’s fifty day moving average is $15.75 and its two-hundred day moving average is $16.33.

The business also recently disclosed a dividend, which will be paid on Thursday, June 16th. Investors of record on Friday, April 29th will be issued a dividend of $0.2432 per share. This represents a yield of 2.63%. The ex-dividend date is Thursday, April 28th.

About Reckitt Benckiser Group (Get Rating)

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Recommended Stories

Get a free copy of the Zacks research report on Reckitt Benckiser Group (RBGLY)

For more information about research offerings from Zacks Investment Research, visit

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with's FREE daily email newsletter.